Clinical Trials Browser

Phase 2/3 × beta-Thalassemia × Sugammadex × Clear all

NCT03728543 2018-11-02

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Phase 2/3 Unknown

Gastrointestinal

Neoplasms, beta-Thalassemia, Hepatoblastoma